Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample

Medical Science Monitor

Volumn 18, Issue 3, 2012, Pages

  Ohaeri, Jude U ^a   Awadalla, Abdel W ^b  

^a Psychological Medicine Hospital Kuwait   (Kuwait)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Anxiety; Comorbidity; Depression; Subthreshold

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARAB; ARTICLE; COMORBIDITY; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DIVORCE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTION; QUALITY OF LIFE; SEX DIFFERENCE; SUICIDAL IDEATION; UNEMPLOYMENT;

EID: 84857883717     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882521     Document Type: Article

References (97)

1. de Graaf R, Bijl RV, Smit P et al: Risk factors for 12-month comorbid-ity of mood, anxiety, and substance use disorders: fndings from the Netherlands mental health survey and incidence study. Am J Psychiatry, 2002; 159: 620-629
2. Das-Munshi J, Goldberg D, Bebbington PE et al: Public health significance of mixed anxiety and depression: beyond current classification. Br J Psychiatry, 2008; 192: 171-177
3. Krueger RF, Markon KE: Reinterpreting comorbidity in a model based approach to understanding and classifying psychopathology. Annu Rev Clin Psychol, 2006; 2: 111-133
4. Cameron OG: Understanding comorbid depression and anxiety. Psychiatr Times, 2007; 24(14)
5. Moftt TE, Harrington H, Caspi A et al: Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry, 2007; 64: 651-660
6. Hirschfeld RMA: The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Primary Care Companion J Clin Psychiatry, 2001; 3: 244-254
7. Kessler RC, Ormel J, Petukhova M et al: Development of lifetime comorbidity in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry, 2011; 68: 90-100
8. Kessler RC, Berglund P, Demler O et al: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry, 2005; 62: 593-602
9. Seedat S, Scott KM, Angermeyer MC et al: Cross-national associations between gender and mental disorders in the WHO World Mental Health Surveys. Arch Gen Psychiatry, 2009; 66: 785-795
10. Scott KM, Von Korff M, Alonso J et al: Age patterns in the prevalence of DSM-IV depressive/anxiety disorders with and without physical co-morbidity. Psychol Med, 2008; 38: 1659-1669
11. Beekman AT, de Beurs E, van Balkom AJ et al: Anxiety and depresión in later life: co-occurrence and communality of risk factors. Am J Psychiatry, 2000; 157: 89-95
12. Judd LL, Akiskal HS, Maser JD et al: A prospective 12-year study of sub-syndromal depressive symptoms in unipolar major depressive disorder. Arch Gen Psychiatry, 1998; 55: 694-700
13. Sadek N, Bona J: Subsyndromal symptomatic depression: a new concept. Depress Anxiety, 2000; 12: 30-39
14. Lawrence AE, Brown TA: Differentiating generalized anxiety disorder from anxiety disorder not otherwise specifed. J Nerv Ment Dis, 2009; 197: 879-886
15. Pincus HA, Davis WW, McQueen LE: 'Subtheshold' mental disorders. A review and synthesis of studies of minor depresión and 'other brand names'. Br J Psychiatry, 1999; 174: 288-296
16. O'Neil KA, Podell JL, Benjamin CL, Kendall PC: Comorbid depressive disorders in anxiety-disordered youth: demographic, clinical and family characteristics. Child Psychiatry Human Development, 2010; 41: 330-341
17. Franco X, Saavedra L, Silverman WK: External validation of comorbid patterns of anxiety disorders in children and adolescents. J Anxiety Disord, 2007; 21: 717-729
18. Small DM, Simons AD, Yovanoff P et al: Silva SG, Lewis CC, Murakami JL, March J: Depressed adolescents and comorbid psychiatric disorders: are there differences in the presentation of depression? J Abnorm Child Psychol, 2008; 36: 1015-1028
19. Masi G, Toni C, Perugi G et al: Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidty. Can J Psychiatry, 2001; 46: 797-802
20. First MB: DSM-5 proposals for mood disorders: a cost - benefit analysis. Curr Opin Psychiatry, 2011; 24: 1-9
21. Jacobi F, Wittchen HU, Holting C et al: Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med, 2004, 34: 597-611
22. Demyttenaere K, Bruffaerts R, Posada-Villa J et al: Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA, 2004; 291: 2581-2590
23. Karam EG, Mneimmeh ZN, Karam AN et al: 12-month prevalence and treatment of mental disorders in Lebanon. Lancet, 2006; 367(9515): 1000-1006
24. Munk-Jorgensen P, Rasmussen I, Allgulander C et al: Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway and Sweden. Psychiatr Serv, 2006; 57: 1738-1744
25. Wittchen HU, Kessler RC, Beesdo K et al: Generalized anxiety and depression in primary care: prevalence, recognition and management. J Clin Psychiatry, 2002; 63(Suppl.8): 24-34
26. Dunlop BW, Davis PG: Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review. Primary Care Companion J Clin Psychiatry, 2008; 10: 222-228
27. Zimmerman M, Chelminski I: Generalized anxiety disorder in patients with major depression: is DSM-IV's hierarchy correct?. Am J Psychiatry, 2003; 160: 504-512
28. Broadhead WE, Blazer DG, George LK, Tse CK: Depression, disability days lost from work in a prospective epidemiologic survey. JAMA, 1990; 264: 2524-2528
29. Rai D, Kosidou K, Lundberg M et al: Psychological distress and risk of long-term disability: population based longitudinal study. J Epidemiol Community Health, 2011; E pub Mar 21
30. Neale MC, Kendler KS: Models of comorbidity for multifactorial disorders. Am J Human Genet, 1995; 57: 935-953
31. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP et al: In search of mixed anxiety-depressive disorder: a primary care study. Depress Anxiety, 2006; 23: 183-189
32. Tyrer P: The case for cothymia: mixed anxiety and depression as a single diagnosis. Br J Psychiatry, 2001; 179: 191-193
33. Tyrer P, Seivewright H, Simmonds S, Johnson T: Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice? Eur Arch Psychiatry Clin Neurosci, 2001; 251(Suppl.2): II53-II56
34. Ohaeri JU: Treatment of anxiety and depression: a review. International J Ment Health Addict, 2006; 4: 103-118
35. Marmorstein NR: Relationship between anxiety and externalizing disorders in youth: the infuence of age and gender. J Anxiety Disord, 2007; 21: 420-432
36. Sunderland M, Mewton L, Slade T, Baillie AJ: Investigating differential symptom profles in major depressive episode with and without generalized anxiety disorder: true comorbidity or symptom similarity? Psychol Med, 2010; 40: 1113-1123
37. Clark LA, Watson D: Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnormal Psychol 1991; 100: 316-336
38. Ohaeri, JU, Awadalla AW, Gado OM: Relationship between symptoms of generalizad anxiety and major depressive disorders using diagnostic criteria - based instruments. Med Sci Monit, 2011; 16(12): PH103-PH115
39. Al-Turkait FA, Ohaeri JU, El-Abassi AM, Naguy A: Relationship between symptoms of anxiety and depression in a sample of Arab college students using the Hopkins Symptoms Checklist - 25. Psychopathology, 2011; 44: 230-241
40. Kendler KS, Aggen SH, Knudsen GP et al: The structure of genetic and environmental risk factors for syndromal and subsyndromal common DSM-IV axis I and all II disorders. Am J Psychiatry, 2011; 168(1): 29-39
41. Kendler KS, Gardner CO: Boundaries of major depression: an evaluation of DSM-IV criteria. Am J Psychiatry, 1998; 155: 172-177
42. Ayuso-Mateos JL, Nuevo R, Verdes E et al: From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiatry, 2010; 196, 365-371
43. Angst J, Cui L, Swendsen J et al: Major depressive disorder with sub-threshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry, 2010; 167: 1194-11201
44. Bener A, Ghuloum S, Abou-Saleh MT: Prevalence, symptom patterns and comorbidity of anxiety and depressive disorders in primary care in Qatar. Soc Psychiatry Psychiatr Epidemiol, 2011; Epub Feb 4
45. Sulaiman N, Hamdan A, Tamin H et al: The prevalence and correlates of depression and anxiety in a sample of diabetic patients in Sharjah, United Arab Emirates. BMC Fam Pract, 2010; 11: 80
46. Daradkeh TK, Ghubash R, Abou-Saleh MT: Al Ain community survey of psychiatric morbidity III: the natural history of psychopathology and the utilization rate of psychiatric services. Soc Psychiatry Psychiatr Epidemiol, 2000; 35: 548-553
47. Lamers F, van Oppen P, Comijs HC et al: Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry, 2011; 72(3): 341-348
48. Simms LJ, Gros DF, Watson D, O'Hara MW: Parsing the general and specific components of depression and anxiety with bifactor modeling. Depress Anxiety, 2008; 25: E34-E46
49. Al Riyani AA, Al Adawi SH, Al Kharusi HA et al: Health services utilization by school going Omani adolescents and youths with DSM-IV mental disorders and barriers to service use. Int J Ment Health Syst, 2009; 3: 22
50. Wang PS, Aguilar-Gaxiola S, Alonso J et al: Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet, 2007; 370: 841-850
51. Skevington SM, Lofty M, O'Connell KA: The World Health Organization's WHOQOL-Bref quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res, 2004; 13: 299-310
52. Spitzer R, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD. JAMA, 1999; 282: 1737-1744
53. Diez-Quevedo C, Rangil T, Sanchez-Planell L et al: Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients. Psychosom Med, 2001; 63: 679-686
54. Seitz DP: Screening mnemonic for generalized anxiety disorder. Can Fam Physician, 2005; 51: 1340-1342
55. Löwe B, Gräfe K, Zipfel S et al: Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom, 2004; 73: 386-390
56. Lubetkin EI, Jia H, Gold MR: Depression, anxiety, and associated health status in low-income Chinese patients. Am J Prev Med, 2003, 24: 354-360
57. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abilgaard W: The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affective Disord, 2001; 66: 159-164
58. Wittchen HU, Boyer P: Screening for anxiety disorders: sensitivity and specificity of the Anxiety Screening Questionnaire (ASQ). Br J Psychiatry, 1998; Suppl 34: 10-17
59. Rief W, Nanke A, Klaiberg A, Braehler E: Base rates for panic and depression according to the Brief Patient Health Questionnaire: a population-based study. J Affect Disord, 2004; 82: 271-276
60. Martin A, Rief W, Klaiberg A, Braehler E: Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry, 2006; 28: 71-77
61. Sen S et al: A prospective cohort study investigating factors associated with depression during internship. Arch Gen Psychiatry, 2010; 67(6): 557-565
62. Wittchen HU, Carter RM, Pfster H et al: Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol, 2000; 15: 319-328
63. Spitzer RL, Kroenke K, Williams JBW, Lowe B: A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Internal Med, 2006; 166: 1092-1097
64. Löwe B, Decker O, Müller S et al: Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care, 2008; 46: 266-274
65. Rodebaugh TL, Holaway RM, Heimberg RG: The factor structure and dimensional scoring of the generalized anxiety disorder questionnaire for DSM-IV. Assessment, 2008; 15: 343-350
66. Newman MG, Zuelling AR, Kachin KE et al: Preliminary reliability and validity of the generalized anxiety disorder questionnaire -IV; a revised self-report diagnostic measure of generalized anxiety disorder. Behav Ther, 2002; 33: 215-233
67. Ruscio AM, Lane M, Roy-Byrne P et al: Should excessive worry be required for a diagnosis of generalized anxiety disorder?. Results from the US National Comorbidity Survey Replication Psychol Med, 2005; 35: 1761-1772
68. Eack SM, Greeno CG, Lee BJ: Limitations of the patient health questionnaire in identifying anxiety and depression in community mental health: many cases are undetected. Res Soc Work Pract, 2006; 16: 625-631
69. Kessler RC, Brandenburg N, Lane M et al: Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med, 2005; 35: 1073-1082
70. Ruscio AM, Chiu WT, Roy-Byrne P et al: Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. J Anxiety Disord, 2007; 21: 662-676
71. Zinbarg RE, Barlow DH, Liebowitz M et al: The DSM-IV field trials for mixed anxiety-depression. Am J Psychiatry, 1994; 151: 1153-1162
72. Ohaeri JU, Awadalla AW: The reliability and validity of the short version of the WHO Quality of Life Instrument (WHOQOL-Brief) in an Arab general population sample. Ann Saudi Med, 2009; 29: 98-104
73. Ohaeri JU, Awadalla AW, El-Abassi AM, Jacob A: Confirmatory factor analytical study of the WHOQOL-Brief: experience with Sudanese general population and psychiatric samples. BMC Med Res Methodol, 2007; 7: 37
74. WHO. WHOQOL User Manual. World Health Organization, Program on Mental Health, Geneva, Switzerland 1998
75. Diener E, Suh EM, Lucas RE, Smith HL: Subjective well-being: three decades of progress. Psychol Bull, 1999; 125: 276-302
76. Cummins RA: Moving from the quality of life concept to a theory. J Intellect Disabl Res, 2005; 49: 699-706
77. Katschnig H: How useful is the concept of quality of life in psychiatry? In: Quality of life in mental disorders. Edited by Katschnig H, Freeman H, Sartorius N: West Sussex, England: John Wiley & Sons Ltd., 2006; 3-17
78. Sprangers MA, Sloan JA, Veenhoven R et al: The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality of life outcomes. Twins Res Hum Genet, 2009; 12: 301-311
79. Sprangers MA, Sloan JA, Barsevick A et al: Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res, 2010; 19: 1395-1403
80. Barsevick A, Frost M, Zwinderman A et al: GENEQOL Consortium: I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res, 2010; 19: 1419-1427
81. Al-Fayez GA, Ohaeri JU: Profile of subjective quality of life and its correlates in a nation-wide sample of high school students in an Arab setting using the WHOQOL-Bref. BMC Psychiatry, 2011; 11: 71
82. Marangell LB, Dennehy EB, Miyahara S et al: The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. J Affect Disord, 2009; 114: 58-67
83. Ohaeri, JU, Awadalla AW, Gado OM: Subjective quality of life in a nationwide sample of Kuwaiti subjects using the short version of the WHO Quality of Life Instrument. Soc Psychiatry Psychiatr Epidemiol, 2009; 44: 693-701
84. van Steen K, Curran D, Kramer J et al: Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identifcation and impact on model selection. Stats Med, 2002; 21: 3865-3884
85. Varni JW, Burwinkle TM, Seid M, Skarr D: The PedsQLTM 4.0 as a pediatric population health measure: feasibility, reliability and validity. Amb Pediatr, 2003; 3: 329-341
86. Krueger RF, Markon KE: Understanding psychopathology: melding behavior genetics, personality, and quantitative psychology to develop and empirically based model. Curr Dir Psychol Sci, 2006; 15: 113-117
87. Ezpeleta L, Domenech JM, Angold A: A comparison of pure and co-morbid CD/ODD and depression. J Child Psychol Psychiatry, 2006; 47: 704-712
88. Watson D, O'Hara MW, Stuart S: Hierarchical structures of affect and psychopathology and their implications for the classification of emotional disorders. Depress Anxiety, 2008; 25: 282-288
89. Watson D: Differentiating the mood and anxiety disorders: a quadripartite model. Annu Rev Psychol, 2009; 5: 221-247
90. Foulds GA, Bedford A: Hierarchy of classes of personal illness. Psychol Med, 1975; 5: 181-192
91. Lawrence AE, Liverant GI, Rosellini AJ, Brown TA: Generalized anxiety disorder within the course of major depressive disorder: examining the utility of the DSM-IV hierarchy rule. Depress Anxiety, 2009; 26: 909-916
92. Aigner M, Forster-Streffeur S, Prause W et al: What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform disorder. Soc Psychiatry Psychiatr Epidemiol, 2006; 41: 81-86
93. Saarni SI, Suvisaari J, Sintonen H et al: Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry, 2007; 190: 326-332
94. Noerholm V, Groenvold M, Watt T et al: Quality of life in the Danish general population - normative data and validity of WHOQOL-Bref using Rasch and item response theory models. Qual Life Res, 2004; 13: 531-540
95. Lyness JM, Chapman BP, McGriff J et al: One-year outcomes of minor and subsyndromal depression in older primary care patients. Int Psychogeratr, 2009; 21: 60-68
96. Pigott HE, Leventhal AM, Alter GS, Boren JJ: Effcacy and effectiveness of antidepressants: current status of research. Psychother Psychosom, 2010; 79: 267-279
97. Tamaniga CA, Davis JM: The neuropharmacology of pstchosis. Schizophr Bull, 2007; 33: 937-946